role of rebates in glp-1 pbm decisions PBMs Help Expand Access and Affordability for GLP‑1 Medications How to Compare PBM Proposals

It is clinically studied and has shown an improvement in blood glucose, cholesterol and body composition over time and in addition to a healthy wellness routine

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

Akkermansia muciniphila produces P9, a small protein that interacts with ICAM-2 to increase thermogenesis and glucagon-like peptide-1 (GLP-1) secretion in mice

In the quest for optimal health, the spotlight is increasingly turning to metabolic balance

Future research is crucial to investigate whether a washout period for GLP-1 agonists before CLN is needed to reduce the risk of AC, if such a risk exists.

Discover how GLP-1 drugs like semaglutide & tirzepatide are transforming obesity care with weight loss results rivaling bariatric surgery.